SS

Sukhdev Singh

Active Director Director DIN 06874414
DIN 06874414 First appointment Jun 2014 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jun 2014
Shareholding value Locked Premium profile

About Sukhdev Singh

Sukhdev Singh has 12 years in corporate governance. Holds Director role. Currently with 1 company, including Velens Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 06874414
Primary Designation Director
First Appointment 09 Jun 2014
Oldest Company Age 12 yrs

Current companies

Company Designation Appointment Founded Status
Director 09 Jun 2014 2014 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Velens Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sukhdev Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sukhdev Singh

Sukhdev Singh has 12 years in corporate governance. Holds Director role. Currently with 1 company, including Velens Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Sukhdev Singh is associated with 1 company as Director.

Sukhdev Singh has expertise in General Business.

Sukhdev Singh has 12 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available